Which hedge funds own UNCY? UNICYCIVE THERAPEUTICS INC, Q2 2026 13F holders

14 tracked hedge funds disclosed a position in UNCY (UNICYCIVE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $24.3m in total. The largest holder by portfolio weight is Diadema Partners LP at 0.5% of its book. 3 opened a new position this quarter: Scientech Research LLC, J. Goldman & Co LP, Caption Management, LLC. 3 exited: Great Point Partners LLC, Integral Health Asset Management, LLC, Renaissance Technologies LLC.

14

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

3

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

3

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$2.4m

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$6.9m

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$24.3m

Combined value

Sum of the holders' reported positions in the security.

1.1%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.